95 related articles for article (PubMed ID: 15935052)
1. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
[TBL] [Abstract][Full Text] [Related]
2. Altered mitochondrial Ca
Yoo H; Park H
Biochem Biophys Res Commun; 2024 Jul; 716():150010. PubMed ID: 38704892
[TBL] [Abstract][Full Text] [Related]
3. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
[TBL] [Abstract][Full Text] [Related]
4. Oxidative metabolism and Ca
Hamilton J; Brustovetsky T; Brustovetsky N
Neurochem Int; 2017 Oct; 109():24-33. PubMed ID: 28062223
[TBL] [Abstract][Full Text] [Related]
5. Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
Wu C; Yin H; Fu S; Yoo H; Zhang M; Park H
Biochem Biophys Res Commun; 2024 Jan; 691():149246. PubMed ID: 38029540
[TBL] [Abstract][Full Text] [Related]
6. Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats.
Gellerich FN; Gizatullina Z; Nguyen HP; Trumbeckaite S; Vielhaber S; Seppet E; Zierz S; Landwehrmeyer B; Riess O; von Hörsten S; Striggow F
J Biol Chem; 2008 Nov; 283(45):30715-24. PubMed ID: 18606820
[TBL] [Abstract][Full Text] [Related]
7. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
Gu X; Greiner ER; Mishra R; Kodali R; Osmand A; Finkbeiner S; Steffan JS; Thompson LM; Wetzel R; Yang XW
Neuron; 2009 Dec; 64(6):828-40. PubMed ID: 20064390
[TBL] [Abstract][Full Text] [Related]
8. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.
Woodman B; Butler R; Landles C; Lupton MK; Tse J; Hockly E; Moffitt H; Sathasivam K; Bates GP
Brain Res Bull; 2007 Apr; 72(2-3):83-97. PubMed ID: 17352931
[TBL] [Abstract][Full Text] [Related]
9. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease.
Lewandowski NM; Bordelon Y; Brickman AM; Angulo S; Khan U; Muraskin J; Griffith EY; Wasserman P; Menalled L; Vonsattel JP; Marder K; Small SA; Moreno H
Neurobiol Dis; 2013 Apr; 52():84-93. PubMed ID: 23220414
[TBL] [Abstract][Full Text] [Related]
10. Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.
Williams BB; Kwakye GF; Wegrzynowicz M; Li D; Aschner M; Erikson KM; Bowman AB
Toxicol Sci; 2010 Sep; 117(1):169-79. PubMed ID: 20547568
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease.
Pellman JJ; Hamilton J; Brustovetsky T; Brustovetsky N
J Neurochem; 2015 Aug; 134(4):652-67. PubMed ID: 25963273
[TBL] [Abstract][Full Text] [Related]
12. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.
Dragileva E; Hendricks A; Teed A; Gillis T; Lopez ET; Friedberg EC; Kucherlapati R; Edelmann W; Lunetta KL; MacDonald ME; Wheeler VC
Neurobiol Dis; 2009 Jan; 33(1):37-47. PubMed ID: 18930147
[TBL] [Abstract][Full Text] [Related]
13. Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington's disease mice.
Alcalá-Vida R; Seguin J; Lotz C; Molitor AM; Irastorza-Azcarate I; Awada A; Karasu N; Bombardier A; Cosquer B; Skarmeta JLG; Cassel JC; Boutillier AL; Sexton T; Merienne K
Nat Commun; 2021 Jan; 12(1):364. PubMed ID: 33441541
[TBL] [Abstract][Full Text] [Related]
14. Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.
Hong C; Seo H; Kwak M; Jeon J; Jang J; Jeong EM; Myeong J; Hwang YJ; Ha K; Kang MJ; Lee KP; Yi EC; Kim IG; Jeon JH; Ryu H; So I
Brain; 2015 Oct; 138(Pt 10):3030-47. PubMed ID: 26133660
[TBL] [Abstract][Full Text] [Related]
15. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
[TBL] [Abstract][Full Text] [Related]
16. Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease.
Donzis EJ; Estrada-Sánchez AM; Indersmitten T; Oikonomou K; Tran CH; Wang C; Latifi S; Golshani P; Cepeda C; Levine MS
Cereb Cortex; 2020 Apr; 30(4):2372-2388. PubMed ID: 31761935
[TBL] [Abstract][Full Text] [Related]
17. Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
Chen GL; Ma Q; Goswami D; Shang J; Miller GM
J Cell Mol Med; 2017 Nov; 21(11):2974-2984. PubMed ID: 28524599
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
Bowles KR; Brooks SP; Dunnett SB; Jones L
PLoS One; 2015; 10(12):e0144864. PubMed ID: 26660732
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.
Rebec GV
Antioxid Redox Signal; 2013 Dec; 19(17):2115-28. PubMed ID: 23642110
[TBL] [Abstract][Full Text] [Related]
20. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
Sánchez I; Mahlke C; Yuan J
Nature; 2003 Jan; 421(6921):373-9. PubMed ID: 12540902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
